​

Cardinal Health (CAH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CAH Stock Forecast

Cardinal Health (CAH) stock forecast, based on 33 Wall Street analysts, predicts a 12-month average price target of $177.00, with a high of $189.00 and a low of $150.00. This represents a 16.09% increase from the last price of $152.47.

$95 $114 $133 $152 $171 $190 High: $189 Avg: $177 Low: $150 Last Closed Price: $152.47

CAH Stock Rating

Cardinal Health stock's rating consensus is Buy, based on 33 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 18 Buy (54.55%), 15 Hold (45.45%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 33 0 15 18 Strong Sell Sell Hold Buy Strong Buy

CAH Price Target Upside V Benchmarks

TypeNameUpside
StockCardinal Health16.09%
SectorHealthcare Stocks 13.55%
IndustryMedical Distribution Stocks13.24%

Price Target Trends

1M3M12M
# Anlaysts247
Avg Price Target$187.50$176.50$167.57
Last Closing Price$152.47$152.47$152.47
Upside/Downside22.98%15.76%9.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 251105--16
Aug, 251104-116
Jul, 252104-117
Jun, 25295-117
May, 25295-117
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 22, 2025Argus Research$189.00$148.1027.62%23.96%
Aug 12, 2025Michael ChernyLeerink Partners$186.00$146.3027.14%21.99%
Aug 12, 2025Brian TanquilutJefferies$150.00$157.66-4.86%-1.62%
Jun 13, 2025Erin WrightMorgan Stanley$181.00$161.4112.14%18.71%
Jun 03, 2025Stephen BaxterWells Fargo$179.00$155.4815.13%17.40%
Feb 04, 2025Kristina RuggeriArgus Research$148.00$125.1718.24%-2.93%
Sep 23, 2024Eric ColdwellRobert W. Baird$140.00$112.3024.67%-8.18%
Sep 11, 2024David ToungArgus Research$125.00$112.3611.25%-18.02%
Aug 16, 2024George HillDeutsche Bank$119.00$107.9110.28%-21.95%
Aug 15, 2024Elizabeth AndersonEvercore ISI$115.00$107.716.77%-24.58%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 13, 2025Wells FargoOverweightOverweighthold
Aug 12, 2025UBSBuyBuyhold
Jun 13, 2025Morgan StanleyOverweightOverweighthold
Jun 13, 2025CitigroupNeutralNeutralhold
Jun 12, 2025Evercore ISIOutperformOutperformhold
Jun 03, 2025Wells FargoUnderweightOverweightupgrade
May 05, 2025Morgan StanleyOverweightOverweighthold
May 01, 2025CitigroupNeutralNeutralhold
Jan 31, 2025Cowen & Co.BuyBuyhold
Jan 10, 2025CitigroupNeutralNeutralhold

Financial Forecast

EPS Forecast

$-5 $-1 $3 $7 $11 $15 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$2.09$-3.34$1.26$3.48$6.48----
Avg Forecast$5.99$5.19$5.74$7.36$7.87$8.76$9.68$10.78$12.76
High Forecast$6.19$5.36$5.87$7.37$7.92$8.95$10.83$11.02$13.05
Low Forecast$5.86$5.07$5.63$7.34$7.78$8.45$7.95$10.56$12.50
Surprise %-65.11%-164.35%-78.05%-52.72%-17.66%----

Revenue Forecast

$150B $190B $230B $270B $310B $350B Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$162.47B$181.36B$205.01B$226.83B$222.58B----
Avg Forecast$160.21B$178.77B$204.30B$225.71B$221.21B$239.25B$256.89B$275.37B$322.52B
High Forecast$164.32B$183.35B$207.84B$226.11B$223.15B$241.57B$257.33B$280.14B$328.11B
Low Forecast$157.40B$175.63B$201.12B$225.39B$219.46B$236.65B$256.45B$271.08B$317.50B
Surprise %1.41%1.45%0.35%0.50%0.62%----

Net Income Forecast

$-1B $-100M $800M $2B $3B $4B Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$611.00M$-933.00M$330.00M$852.00M$1.56B----
Avg Forecast$1.20B$601.41M$1.42B$1.28B$1.94B$2.15B$2.32B$2.66B$3.15B
High Forecast$1.51B$721.69M$1.45B$1.83B$1.96B$2.21B$2.67B$2.72B$3.22B
Low Forecast$896.01M$481.12M$1.39B$734.28M$1.92B$2.09B$1.96B$2.61B$3.09B
Surprise %-49.25%-255.14%-76.74%-33.44%-19.45%----

CAH Forecast FAQ

Is Cardinal Health stock a buy?

Cardinal Health stock has a consensus rating of Buy, based on 33 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 18 Buy, 15 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cardinal Health is a favorable investment for most analysts.

What is Cardinal Health's price target?

Cardinal Health's price target, set by 33 Wall Street analysts, averages $177 over the next 12 months. The price target range spans from $150 at the low end to $189 at the high end, suggesting a potential 16.09% change from the previous closing price of $152.47.

How does Cardinal Health stock forecast compare to its benchmarks?

Cardinal Health's stock forecast shows a 16.09% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and outperforming the medical distribution stocks industry (13.24%).

What is the breakdown of analyst ratings for Cardinal Health over the past three months?

  • September 2025: 6.25% Strong Buy, 62.50% Buy, 31.25% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 6.25% Strong Buy, 62.50% Buy, 25.00% Hold, 0% Sell, 6.25% Strong Sell.
  • July 2025: 11.76% Strong Buy, 58.82% Buy, 23.53% Hold, 0% Sell, 5.88% Strong Sell.

What is Cardinal Health’s EPS forecast?

Cardinal Health's average annual EPS forecast for its fiscal year ending in June 2026 is $8.76, marking a 35.19% increase from the reported $6.48 in 2025. Estimates for the following years are $9.68 in 2027, $10.78 in 2028, and $12.76 in 2029.

What is Cardinal Health’s revenue forecast?

Cardinal Health's average annual revenue forecast for its fiscal year ending in June 2026 is $239.25B, reflecting a 7.49% increase from the reported $222.58B in 2025. The forecast for 2027 is $256.89B, followed by $275.37B for 2028, and $322.52B for 2029.

What is Cardinal Health’s net income forecast?

Cardinal Health's net income forecast for the fiscal year ending in June 2026 stands at $2.15B, representing an 37.67% increase from the reported $1.56B in 2025. Projections indicate $2.32B in 2027, $2.66B in 2028, and $3.15B in 2029.